stars 1 stars 2 stars 3

Stroke is the 2nd leading cause of death worldwide, affecting 100 million people, and the leading cause of death among women in France, while dementia currently affects 57 million people (a figure that could triple by 2050). By bringing together world-renowned researchers, clinicians and industry partners in a state-of-the-art facility, the VBHI aims to develop a new paradigm for preventing stroke and dementia while promoting healthy brain ageing on a local, national and global scale. The VBHI is a university hospital institute dedicated to cerebrovascular health based in Bordeaux. Housed within the Fondation Bordeaux Université, its founders are the University of Bordeaux, Bordeaux University Hospital, Inserm, Inria and the Region Nouvelle-Aquitaine. The VBHI institute receives government funding managed by the Agence Nationale de la Recherche (French National Research Agency) under the France 2030 programme, under the reference "ANR-23-IAHU-0001".

VBHI Questions

Michel de Schotten is the Deputy Director of VBHI.

10 people are employed at VBHI.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users